E-mails suggest Pfizer tried to suppress study on drug – The Boston Globe.
Here we go again. Not just Vioxx and the ghost writing scare but now also Neurontin. Emails can get your company in a lot of trouble
Related articles
- Pfizer’s Arthritis Treatment Wins Approval From US FDA – Bloomberg (bloomberg.com)
- Pfizer’s Xeljanz story reveals why new drug development requires luck, money, endurance (medcitynews.com)
- Can The Boston Globe and MIT hack the future of news together? By @JustinNXT (nextlevelofnews.com)
- Pfizer caught “gaming the system,” loses Viagra patent in Canada (arstechnica.com)
- FDA hands Pfizer blockbuster approval for rheumatoid arthritis drug tofacitinib (fiercebiotech.com)
- Supreme Court of Canada rules Pfizer’s Viagra patent is invalid (vancouversun.com)
- State pharmacy board director fired in wake of meningitis outbreak (bizjournals.com)